AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteIdazoxan hydrochloride is an α2-AR adrenoceptor antagonist and potential I2 imidazoline receptor agonist. Also displays I1 imidazoline receptor antagonist activity. (pKi values are 5.90, 7.22, 8.01, 7.43, and 7.7 for I1, I2, α 2A, α2B, and α 2C receptors respectively).
More Information Supplier PageIdazoxan hydrochloride is an α2-AR adrenoceptor antagonist and potential I2 imidazoline receptor agonist. Also displays I1 imidazoline receptor antagonist activity. (pKi values are 5.90, 7.22, 8.01, 7.43, and 7.7 for I1, I2, α 2A, α2B, and α 2C receptors respectively).
More Information Supplier PageIdazoxan hydrochloride is an α2-AR adrenoceptor antagonist and potential I2 imidazoline receptor agonist. Also displays I1 imidazoline receptor antagonist activity. (pKi values are 5.90, 7.22, 8.01, 7.43, and 7.7 for I1, I2, α 2A, α2B, and α 2C receptors respectively).
More Information Supplier PageChemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).
More Information Supplier PageChemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).
More Information Supplier PageChemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).
More Information Supplier PageIDO inhibitor1 is a potent and novel indoleamine-2, 3 dioxygenase (ISO)inhibitor with an IC 50 value
More Information Supplier PageIDO inhibitor1 is a potent and novel indoleamine-2, 3 dioxygenase (ISO)inhibitor with an IC 50 value
More Information Supplier PageIDO inhibitor1 is a potent and novel indoleamine-2, 3 dioxygenase (ISO)inhibitor with an IC 50 value
More Information Supplier PageIEM 1754 Dihydrobromide is a voltage-dependent open-channel blocker of AMPA receptors.
More Information Supplier PageIEM 1754 Dihydrobromide is a voltage-dependent open-channel blocker of AMPA receptors.
More Information Supplier PageIEM 1754 Dihydrobromide is a voltage-dependent open-channel blocker of AMPA receptors.
More Information Supplier PageIEM 1754 Dihydrobromide is a voltage-dependent open-channel blocker of AMPA receptors.
More Information Supplier PageIEM 1754 Dihydrobromide is a voltage-dependent open-channel blocker of AMPA receptors.
More Information Supplier PageIfosfamide is a cytostatic agent that is structurally related to cyclophosphamide.
More Information Supplier PageIfosfamide is a cytostatic agent that is structurally related to cyclophosphamide.
More Information Supplier PageIfosfamide is a cytostatic agent that is structurally related to cyclophosphamide.
More Information Supplier PageIfosfamide is a cytostatic agent that is structurally related to cyclophosphamide.
More Information Supplier PageIfosfamide is a cytostatic agent that is structurally related to cyclophosphamide.
More Information Supplier PageIguratimod(T 614) is one of a series of 4H-1-benzopyran-4-ones which has potent anti-inflammatory, analgesic and antipyretic activity. Iguratimod(T 614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.
More Information Supplier PageIguratimod(T 614) is one of a series of 4H-1-benzopyran-4-ones which has potent anti-inflammatory, analgesic and antipyretic activity. Iguratimod(T 614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.
More Information Supplier PageIguratimod(T 614) is one of a series of 4H-1-benzopyran-4-ones which has potent anti-inflammatory, analgesic and antipyretic activity. Iguratimod(T 614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.
More Information Supplier PageIguratimod(T 614) is one of a series of 4H-1-benzopyran-4-ones which has potent anti-inflammatory, analgesic and antipyretic activity. Iguratimod(T 614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.
More Information Supplier PageIKK 16 is a selective I??B kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
More Information Supplier PageIKK 16 is a selective I??B kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
More Information Supplier PageIKK 16 is a selective I??B kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
More Information Supplier PageIKK 16 is a selective I??B kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
More Information Supplier PageIKK 16 is a selective I??B kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIM-12 is a cell-permeable indolylmaleimide that acts as a Glycogen synthase kinase 3?? (GSK-3??) inhibitor, activating downstream components of canonical Wnt signaling.
More Information Supplier PageIM-12 is a cell-permeable indolylmaleimide that acts as a Glycogen synthase kinase 3?? (GSK-3??) inhibitor, activating downstream components of canonical Wnt signaling.
More Information Supplier PageIM-12 is a cell-permeable indolylmaleimide that acts as a Glycogen synthase kinase 3?? (GSK-3??) inhibitor, activating downstream components of canonical Wnt signaling.
More Information Supplier PageIM-12 is a cell-permeable indolylmaleimide that acts as a Glycogen synthase kinase 3?? (GSK-3??) inhibitor, activating downstream components of canonical Wnt signaling.
More Information Supplier PageIM-12 is a cell-permeable indolylmaleimide that acts as a Glycogen synthase kinase 3?? (GSK-3??) inhibitor, activating downstream components of canonical Wnt signaling.
More Information Supplier PageiMAC2 inhibits mitochondrial apoptosis-induced channel (MAC) (IC50 = 28 nM).
More Information Supplier PageiMAC2 inhibits mitochondrial apoptosis-induced channel (MAC) (IC50 = 28 nM).
More Information Supplier PageImatinib (Gleevec) is a number of tyrosine kinase enzymes specific inhibitor.
More Information Supplier PageImatinib (Gleevec) is a number of tyrosine kinase enzymes specific inhibitor.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageIMD 0354 is an inhibitor of I??B kinase-?? (IKK??) that blocks NF-??B nuclear translocation.
More Information Supplier Page
